News Releases

Alamo Pharma Services COO Shares Keys to Successful Pharmaceutical Product Launches at Second Annual Life Sciences Summit
Conference attendees learned pitfalls to avoid when launching pharmaceutical drugs in U.S. market.

DOYLESTOWN, Pa., July 21, 2016 /PRNewswire/ -- On June 29, 2016, Peter Marchesini, Chief Operating Officer of Alamo Pharma Services®, participated in CBI's Second Annual Life Sciences Product Launch Summit in Philadelphia. The "Ask the Experts" topic was titled "Learn from Recent Pitfalls to Prepare for Future Product Launches." They thoroughly analyzed recent product launches and discussed the most common and detrimental difficulties anticipated when trying to launch a product and how to possibly avoid them.

"Ask the Experts" panel included Jorge Lorenzo, Executive Director - Commercialization, Noven Pharmaceuticals; Gary Pyner, Chief Commercial Officer, Asklepion Pharmaceuticals LLC; Neeveen Abou-Gharbia, PharmD, Director, CNS Global Marketing & LCM, Otsuka America Pharmaceuticals; Peter Marchesini, Chief Operating Officer, Alamo Pharma Services; and Ted Hoffman, Leader of North America Launch Excellence and Commercial Projects, Teva Pharmaceuticals.

This summit was attended by more than 50 leaders in life sciences companies. The goal of CBI's summit was to provide the product launch market with leading-edge, actionable information on the most compelling industry mega and micro trends through exclusive thought leadership presentations from their well-respected speaking faculty and government officials.

"We were honored to be included in this prestigious summit as CBI is known for creating compelling content and personal connections within the Life Science industry," says Marchesini. "Alamo Pharma Services offers pharmaceutical and biotech companies an innovative and thoughtful approach to deploying high impact sales teams. Our company is simple to work with, offering a turnkey approach for our clients in the areas of recruiting, hiring, training, and ongoing operational support of the sales team.  No two solutions are the same. Alamo specializes in helping companies define the smartest plan to effectively address the opportunity, to maximize their return on investment."

Marchesini's expertise is further enhanced by his role on the faculty at Rutgers Business School, co-teaching the course, Managing the Pharmaceutical Sales Force, which is a core course of the Pharmaceutical MBA program. With more than 20 years of experience in the pharmaceutical industry, Marchesini leads the operational efforts of Alamo Pharma Services to provide clients unmatched customer support.

About Alamo Pharma Services

Founded in 2011, Alamo Pharma Services offers pharmaceutical and biotech companies vital solutions to bring their products to market efficiently and successfully. Based out of its offices in Doylestown, Pa., Alamo Pharma Services offers companies vast commercialization experience, customized recruiting of your sales team, superior training, and committed support services. For more information regarding Alamo Pharma Services, visit alamopharmaservices.com, call (215) 489-9505, or email newbusiness@alamopharmaservices.com.

Alamo Pharma Services, Inc. is a part of the Mission family of companies.  BioComp Pharma, Inc., a generic drug distributor; ProSolus, Inc., a transdermal drug developer and manufacturer; BexR Logistix, LLC, a logistics and fulfillment company; and Espada Dermatology, Inc., an esthetic dermatology company.  To learn more, please visit missionpharmacal.com.

Chief Operating Officer of Alamo Pharma Services Peter Marchesini at the Second Annual Life Sciences Product Launch Summit in Philadelphia on June 29.

 

Photo - http://photos.prnewswire.com/prnh/20160721/391902
Photo - http://photos.prnewswire.com/prnh/20160721/391901

SOURCE Alamo Pharma Services

For further information: Drew Deeter, DeeterUSA, Integrated Marketing & Communications, 215.348.3890, drew@deeterusa.com